No specific information is available on the treatment of overdose with montelukast.
Effects of Montelukast and Budesonide on Airway Responses and Airway Inflammation in Asthma.
Do not take this medication if you are allergic to montelukast or any ingredients of the medication.
The estimated difference between SINGULAIR and placebo was -0. The ethnic racial distribution in these studies was 71. Following an oral dose of radiolabeled montelukast, 86 of the radioactivity was recovered in 5-day fecal collections and. The frequency of less common adverse events was comparable between SINGULAIR and placebo. They will decide what to do based on your child s condition and the specific medicine involved.
Our information sometimes differs from that provided by the manufacturers, because their information is usually aimed at adult patients. Patients who develop these symptoms should be reassessed and their treatment regimens evaluated.
Ask your doctor before use if you are taking the following medications:
Frequency of hepatotoxicity could be higher in adolescents than in adults.
If calcium supplements must be prescribed, serum calcium levels should be monitored and calcium dosage should be adjusted accordingly.
These findings occurred in the presence of maternal toxicity.
There have been occasional reports of aggressive behaviour or hostility, anxiousness, disorientation or decreased memory. Withdrawal of montelukast during the washout period did not cause an increased incidence of worsening asthma as compared with placebo. However, it has been reported that the symptoms of allergic granulomatous angiitis disappeared in some patients after withdrawing montelukast.
MSD 711 on one side and SINGULAIR on the other.